Curtiss, III; Roy

Patent Applications and Registrations

Patent applications and USPTO patent grants for Curtiss, III; Roy.The latest application filed is for "regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety".

Company Profile

10.54.42

Curtiss, III; Roy - Gainesville FL
Curtiss, III; Roy - Paradise Valley AZ
Curtiss, III; Roy - Tempe AZ
Curtiss, III; Roy - St. Louis MO
Curtiss, III; Roy - Birmingham AL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Regulated Expression Of Antigen And/or Regulated Attenuation To Enhance Vaccine Immunogenicity And/or Safety App 20220090097 - Curtiss, III; Roy ; et al.	2022-03-24
Live Self-destructing Bacterial Adjuvants To Enhance Induction Of Immunity App 20220001008 - CURTISS, III; Roy	2022-01-06
Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety Grant 11,180,765 - Curtiss, III , et al. November 23, 2	2021-11-23
Protective anti-ZIKV vaccine without inducing cross-reactions with dengue Grant 11,136,354 - Curtiss, III October 5, 2	2021-10-05
Food Safety Vaccine To Control Salmonella Enterica And Reduce Campylobacter In Poultry App 20210283235 - Curtiss, III; Roy ; et al.	2021-09-16
Induction Of Protective Immunity Against Antigens App 20210284955 - Curtiss, III; Roy ; et al.	2021-09-16
Food safety vaccine to control Salmonella enterica and reduce campylobacter in poultry Grant 11,000,583 - Curtiss, III , et al. May 11, 2	2021-05-11
Induction of protective immunity against antigens Grant 10,988,729 - Curtiss, III , et al. April 27, 2	2021-04-27
Ichthyophthirius Multifiliis Vaccine System App 20210093704 - CURTISS, III; Roy ; et al.	2021-04-01
Regulated Expression Of Antigen And/or Regulated Attenuation To Enhance Vaccine Immunogenicity And/or Safety App 20200377897 - Curtiss, III; Roy ; et al.	2020-12-03
Induction Of Protective Immunity Against Antigens App 20200368339 - Curtiss, III; Roy ; et al.	2020-11-26
Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety Grant 10,774,334 - Curtiss, III , et al. Sept	2020-09-15
Regulated Expression Of Antigen And/or Regulated Attenuation To Enhance Vaccine Immunogenicity And/or Safety App 20200165620 - Curtiss, III; Roy ; et al.	2020-05-28
A Food Safety Vaccine To Control Salmonella Enterica And Reduce Campylobacter In Poultry App 20200009240 - Curtiss, III; Roy ; et al.	2020-01-09
Induction Of Protective Immunity Against Antigens App 20190382717 - Curtiss, III; Roy ; et al.	2019-12-19
Design Of Protective Anti-zikv Vaccine Without Inducing Cross-reactions With Dengue App 20190185520 - CURTISS, III; ROY	2019-06-20
Regulated Expression Of Antigen And/or Regulated Attenuation To Enhance Vaccine Immunogenicity And/or Safety App 20180320189 - Curtiss, III; Roy ; et al.	2018-11-08
Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety Grant 9,885,051 - Curtiss, III , et al. February 6, 2	2018-02-06
Attenuated Live Bacteria With Increased Acid Resistance And Methods Of Use Thereof App 20170327830 - Curtiss, III; Roy ; et al.	2017-11-16
Recombinant Bacterium To Decrease Tumor Growth App 20170306338 - Curtiss, III; Roy ; et al.	2017-10-26
Recombinant Bacterium And Methods Of Antigen And Nucleic Acid Delivery App 20170224806 - Curtiss, III; Roy ; et al.	2017-08-10
Attenuated live bacteria with increased acid resistance and methods of use thereof Grant 9,580,718 - Curtiss, III , et al. February 28, 2	2017-02-28
Recombinant bacterium and methods of antigen and nucleic acid delivery Grant 9,481,888 - Curtiss, III , et al. November 1, 2	2016-11-01
Microbes With Controlled Adhesive Properties App 20160251610 - Fisher; Michael L. ; et al.	2016-09-01
Regulated Expression Of Antigen And/or Regulated Attentuation To Enhance Vaccine Immunogenicity And/or Safety App 20160199467 - Curtiss, III; Roy ; et al.	2016-07-14
Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety Grant 9,297,015 - Curtiss, III , et al. March 29, 2	2016-03-29
Compositions and methods for bacterial lysis and neutral lipid production Grant 9,255,283 - Curtiss, III , et al. February 9, 2	2016-02-09
Single expression vector for generation of a virus with a segmented genome Grant 9,163,219 - Curtiss, III , et al. October 20, 2	2015-10-20
Yersinia pestis vaccine Grant 9,062,297 - Curtiss, III , et al. June 23, 2	2015-06-23
Recombinant bacterium capable of eliciting an immune response against Streptococcus pneumoniae Grant 9,050,285 - Curtiss, III , et al. June 9, 2	2015-06-09
Recombinant Edwardsiella bacterium Grant 9,045,742 - Curtiss, III , et al. June 2, 2	2015-06-02
Recombinant bacterium capable of eliciting a protective immune response against C. perfringens Grant 9,040,059 - Curtiss, III , et al. May 26, 2	2015-05-26
Microbes With Controlled Adhesive Properties App 20150140666 - Fisher; Michael L. ; et al.	2015-05-21
Recombinant Bacterium For Induction Of Cellular Immune Response App 20150056232 - Curtiss, III; Roy	2015-02-26
Attenuated Live Bacteria With Increased Acid Resistance And Methods Of Use Thereof App 20140370057 - Curtiss, III; Roy ; et al.	2014-12-18
Bacterium comprising a regulated rfaH nucleic acid Grant 8,889,121 - Curtiss, III , et al. November 18, 2	2014-11-18
Recombinant Bacterium To Decrease Tumor Growth App 20130209405 - Curtiss, III; Roy ; et al.	2013-08-15
Compositions And Methods For Bacterial Lysis And Neutral Lipid Production App 20130196394 - Curtiss, III; Roy ; et al.	2013-08-01
Regulated Expression Of Antigen And/or Regulated Attentuation To Enhance Vaccine Immunogenicity And/or Safety App 20130171190 - Curtiss III; Roy ; et al.	2013-07-04
Recombinant bacterium capable of eliciting an immune response against enteric pathogens Grant 8,465,755 - Curtiss, III , et al. June 18, 2	2013-06-18
Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety Grant 8,445,254 - Curtiss, III , et al. May 21, 2	2013-05-21
BACTERIUM COMPRISING A REGULATED rfaH NUCLEIC ACID App 20130004537 - Curtiss, III; Roy ; et al.	2013-01-03
Bacterium For Production Of Fatty Acids App 20120237987 - Curtiss, III; Roy ; et al.	2012-09-20
Recombinant Bacterium And Methods Of Antigen And Nucleic Acid Delivery App 20120087946 - Curtiss III; Roy ; et al.	2012-04-12
Regulated attenuation of live vaccines to enhance cross-protective immunogenicity Grant 8,133,493 - Curtiss, III March 13, 2	2012-03-13
Recombinant Bacterium Capable Of Eliciting An Immune Response Against Streptococcus Pneumoniae App 20110287052 - Curtiss, III; Roy ; et al.	2011-11-24
Yersinia Pestis Vaccine App 20110256177 - Curtiss, III; Roy ; et al.	2011-10-20
Recombinant Bacterium Capable Of Eliciting A Protective Immune Response Against C. Perfringens App 20110256181 - Curtiss, III; Roy ; et al.	2011-10-20
Nucleic Acids, Bacteria, And Methods For Degrading The Peptidoglycan Layer Of A Cell Wall App 20110159594 - Curtiss, III; Roy ; et al.	2011-06-30
Recombinant Bacterium Capable Of Eliciting An Immune Response Against Enteric Pathogens App 20110033501 - Curtiss iii; Roy ; et al.	2011-02-10
Recombinant bacterial vaccine system with environmentally limited viability Grant 7,871,604 - Curtiss, III , et al. January 18, 2	2011-01-18
Recombinant Bacteria Comprising Vectors For Expression Of Nucleic Acid Sequences Encoding Antigens App 20100317084 - Curtiss, III; Roy	2010-12-16
Recombinant Edwardsiella Bacterium App 20100303863 - Curtiss, III; Roy ; et al.	2010-12-02
Single Expression Vector For Generation Of A Virus With A Segmented Genome App 20100285592 - Curtiss, III; Roy ; et al.	2010-11-11
Regulated Expression Of Antigen And/or Regulated Attentuation To Enhance Vaccine Immunogenicity And/or Safety App 20100124558 - Curtiss III; Roy ; et al.	2010-05-20
Regulated antigen delivery system (RADS) Grant 7,341,860 - Curtiss, III , et al. March 11, 2	2008-03-11
Modulation of immune responses to foreign antigens expressed by recombinant attenuated bacterial vectors Grant 7,195,757 - Curtiss, III , et al. March 27, 2	2007-03-27
Recombinant vaccines comprising immunogenic attenuated bacteria having RpoS positive phenotype Grant 7,083,794 - Curtiss, III , et al. August 1, 2	2006-08-01
Functional balanced-lethal host-vector systems Grant 6,872,547 - Curtiss, III March 29, 2	2005-03-29
Regulated antigen delivery system (RADS) Grant 6,780,405 - Curtiss, III , et al. August 24, 2	2004-08-24
Regulated antigen delivery system (rads) App 20040137003 - Curtiss III, Roy	2004-07-15
Recombinant bacterial system with environmentally limited viability Grant 6,610,529 - Curtiss, III , et al. August 26, 2	2003-08-26
Recombinant vaccines comprising immunogenic attenuated bacteria having RPOS positive phenotype Grant 6,383,496 - Curtiss, III , et al. May 7, 2	2002-05-07
Recombinant avirulent immunogenic S typhi having rpos positive phenotype Grant 6,024,961 - Curtiss, III , et al. February 15, 2	2000-02-15
Recombinant avirulent bacterial antigen delivery system Grant 5,888,799 - Curtiss, III March 30, 1	1999-03-30
Avirulent microbes and uses therefor Grant 5,855,880 - Curtiss, III , et al. January 5, 1	1999-01-05
Avirulent microbes and uses therefor Grant 5,855,879 - Curtiss III January 5, 1	1999-01-05
Oral immunization by transgenic plants Grant 5,686,079 - Curtiss, III , et al. November 11, 1	1997-11-11
Oral immunization by transgenic plants Grant 5,679,880 - Curtiss, III , et al. October 21, 1	1997-10-21
Selective maintenance of a recombinant gene in a population of vaccine cells Grant 5,672,345 - Curtiss, III September 30, 1	1997-09-30
Recombinant avirulent salmonella antifertility vaccines Grant 5,656,488 - Curtiss, III , et al. August 12, 1	1997-08-12
Oral immunization by transgenic plants Grant 5,654,184 - Curtiss, III , et al. August 5, 1	1997-08-05
Avirulent microbes and uses therefor Grant 5,468,485 - Curtiss, III * November 21, 1	1995-11-21
Vaccines containing avirulent phop-type microorganisms Grant 5,424,065 - Curtiss, III , et al. June 13, 1	1995-06-13
Avirulent microbes and uses therefor: Salmonella typhi Grant 5,387,744 - Curtiss, III , et al. * February 7, 1	1995-02-07
Avirulent microbes and uses therefor: salmonella typhi Grant 5,294,441 - Curtiss, III March 15, 1	1994-03-15
Modified microorganisms and method of preparing and using same Grant 4,968,619 - Curtiss, III November 6, 1	1990-11-06
Vaccines obtained from antigenic gene products of recombinant genes Grant 4,888,170 - Curtiss, III December 19, 1	1989-12-19
Modified microorganisms and method of preparing and using same Grant 4,190,495 - Curtiss, III February 26, 1	1980-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.